NCT02022124View on ClinicalTrials.gov

Open Label Placebo in the Treatment of Low Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Chronic Low Back Pain
Interventions
DRUG

Microcrystalline cellulose (open-label inert substance)

The intervention will be an inert substance, microcrystalline cellulose in a capsule. Participants will take two capsules daily.

Trial Locations (1)

1349-019

Hospital de Egas Moniz, Lisbon

All Listed Sponsors
lead

Hospital de Egas Moniz

OTHER

NCT02022124 - Open Label Placebo in the Treatment of Low Back Pain | Biotech Hunter | Biotech Hunter